Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Oncoimmunology
|
March 12, 2020
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Shyambabu Chaurasiya, Annie Yang, Seonah Kang, et al.
Molecular Therapy. Oncology
|
July 13, 2026
Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis
Zhifang Zhang, Annie Yang, Anthony K Park, et al.
Molecular Therapy Oncolytics
|
July 11, 2018
A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
Michael P O'Leary, Susanne G Warner, Sang-In Kim, et al.
Journal of Translational Medicine
|
April 28, 2018
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
Michael P O'Leary, Audrey H Choi, Sang-In Kim, et al.
Molecular Cancer Therapeutics
|
December 2, 2020
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
Sang-In Kim, Anthony K Park, Shyambabu Chaurasiya, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 24, 2025
Oncolytic Virotherapy in Solid Tumors: A Current Review
Courtney Chen, Jennifer Cillis, Supriya Deshpande, et al.
Journal for Immunotherapy of Cancer
|
April 1, 2026
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory
Annie Yang, Zhifang Zhang, Anthony K Park, et al.
Cancer Gene Therapy
|
June 10, 2021
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Science Translational Medicine
|
September 4, 2020
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
Anthony K Park, Yuman Fong, Sang-In Kim, et al.
Molecular Therapy Oncolytics
|
March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
Sang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Oncoimmunology
|
March 12, 2020
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model
Shyambabu Chaurasiya, Annie Yang, Seonah Kang, et al.
Molecular Therapy. Oncology
|
July 13, 2026
Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis
Zhifang Zhang, Annie Yang, Anthony K Park, et al.
Molecular Therapy Oncolytics
|
July 11, 2018
A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection
Michael P O'Leary, Susanne G Warner, Sang-In Kim, et al.
Journal of Translational Medicine
|
April 28, 2018
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose
Michael P O'Leary, Audrey H Choi, Sang-In Kim, et al.
Molecular Cancer Therapeutics
|
December 2, 2020
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity
Sang-In Kim, Anthony K Park, Shyambabu Chaurasiya, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
September 24, 2025
Oncolytic Virotherapy in Solid Tumors: A Current Review
Courtney Chen, Jennifer Cillis, Supriya Deshpande, et al.
Journal for Immunotherapy of Cancer
|
April 1, 2026
Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory
Annie Yang, Zhifang Zhang, Anthony K Park, et al.
Cancer Gene Therapy
|
June 10, 2021
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Science Translational Medicine
|
September 4, 2020
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
Anthony K Park, Yuman Fong, Sang-In Kim, et al.
Molecular Therapy Oncolytics
|
March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
Sang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Page
of 7